Table 3 XPF expression in CRC, adenoma and anal benign disease tissue
From: XPF expression and its relationship with the risk and prognosis of colorectal cancer
Category | Group | Cases | (−) | (+) | (++) | (+++) | PR (%) | P |
|---|---|---|---|---|---|---|---|---|
n (%) | n (%) | n (%) | n (%) | |||||
Overall | CRC | 276 | 131 | 116 | 17 | 12 | 52.5% | <0.001 |
Adenoma | 202 | 116 | 67 | 15 | 4 | 42.6% | ||
Anal disease | 62 | 55 | 6 | 1 | 0 | 11.3% | ||
Male | CRC | 143 | 66 | 62 | 9 | 6 | 53.8% | <0.001 |
Adenoma | 24 | 19 | 4 | 0 | 1 | 20.8% | ||
Anal disease | 19 | 17 | 1 | 1 | 0 | 10.5% | ||
Female | CRC | 105 | 58 | 39 | 6 | 2 | 44.8% | 0.001 |
Adenoma | 26 | 16 | 6 | 2 | 2 | 38.5% | ||
Anal disease | 42 | 37 | 5 | 0 | 0 | 11.9% | ||
≤60 | CRC | 119 | 62 | 47 | 7 | 3 | 47.9% | 0.001 |
Adenoma | 26 | 18 | 6 | 1 | 1 | 30.8% | ||
Anal disease | 38 | 32 | 5 | 1 | 0 | 15.8% | ||
>60 | CRC | 129 | 62 | 54 | 8 | 5 | 51.9% | <0.001 |
Adenoma | 24 | 17 | 4 | 1 | 2 | 29.2% | ||
Anal disease | 22 | 21 | 1 | 0 | 0 | 4.5% | ||
Colon | CRC | 82 | 54 | 21 | 3 | 4 | 34.1% | 0.275 |
Adenoma | 10 | 8 | 2 | 0 | 0 | 20.0% | ||
Rectum | CRC | 166 | 70 | 80 | 12 | 4 | 57.8% | 0.109 |
Adenoma | 33 | 22 | 6 | 2 | 3 | 33.3% |